Other behavioral tests, for example the rotarod test and tail suspension test, were also examined but no significant effects were observed following chronic MPTP infusion (data not shown).
Wisp1 and Wisp3 mRNA expression was not affected by AGE-treated MSA infusion (data not shown).
MyD88 and CD14 expression was not significantly altered following insulin infusion (data not shown).
Capnia, body temperature, vasoactive drugs were not significantly modified during the infusion (data not shown).
TF2 clearance was not related to the CEA plasma level at the time of infusion (data not shown).
No vascular occlusion was detected in lung, liver, spleen and brain for three days post-infusion (data not shown).
The only symptom reported was grade II vomiting in one patient after the first I-MIBG infusion (data not shown).
Moreover, the numbers of TUNEL-positive cardiomyocytes were comparable between WT and KO mice following 7 days of Ang II infusion (data not shown).
In all cases specific cDNA products of the predicted size were detected in samples at one, two and three days, post-infusion (data not shown).
